Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
Aminoglycoside Extended-Interval DosingAminoglycoside Renal DoseAminoglycoside Traditional DosingAmphotericin B Dosing WeightAugmented Renal Clearance ScoreAzathioprine / 6-MP DoseBuprenorphine-Naloxone InductionCarboplatin Calvert FormulaCefepime Renal DoseChild-Pugh Dose AdjustmentCisplatin BSA DosingColchicine Renal DoseCreatinine Clearance Multi-MethodCyclosporine DoseDOAC Renal Dose SelectorDigoxin Loading and MaintenanceFentanyl Patch ConversionFluconazole Renal DoseFlumazenil DosingFosphenytoin ConversionGabapentin Renal DoseHeparin Weight-Based DosingLMWH Prophylactic DosingLMWH Therapeutic DosingLithium Dosing NomogramLithium Renal DoseMeropenem Renal DoseMetformin Renal SafetyMethotrexate DoseMycophenolate Mofetil DoseN-Acetylcysteine DosingNSAID Renal SafetyNaloxone DosingOpioid Equianalgesic ConverterOpioid RotationOral MEDDPhenytoin Loading DosePiperacillin-Tazobactam Renal DoseProtamine ReversalRituximab BSA DosingSteroid EquivalencyStress Dose SteroidsTacrolimus Target TroughTheophylline Loading and MaintenanceVancomycin AUC-Guided DosingVancomycin Renal DoseVancomycin Trough-Only DosingWarfarin Dose AdjustmentWarfarin Initiation Nomogram
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

Cancer MedicineJun 13, 2026
SGO1 and SGO2 are Associated With Disease Progression and an Immunosuppressive Microenvironment in Papillary Renal Cell Carcinoma

Clinical Context

We think this might be relevant to the clinical guidance for DOAC Renal Dose Selector — Atrial Fibrillation & VTE.

Clinical Pharmacology TherapeuticsJun 2, 2026
Street Pharmacology: The Mechanistic Basis of Clinical Pharmacology Underlying the Microdosing Method of Buprenorphine–Naloxone With a Focus on the Unhoused Population

Clinical Context

We think this has broad domain relevance to DOAC Renal Dose Selector — Atrial Fibrillation & VTE.

Clinical Pharmacology TherapeuticsJun 1, 2026
Acetylation Variability in Elderly Tunisians: Implications for Isoniazid Dose Individualization

Clinical Context

We think this might be relevant to the clinical guidance for DOAC Renal Dose Selector — Atrial Fibrillation & VTE.